Crosen Soft Capsules (Clonixin Lysine Salt)

Adult dose

Adults: Administer 125∼250 mg of clonixin lysinate orally 3 times daily.

This medication should be consulted with a doctor or pharmacist if the patient regularly consumes more than three drinks a day, as it may increase the risk of gastrointestinal bleeding. In patients with cardiovascular diseases or risk factors, caution is required as this medication may increase the likelihood of serious cardiovascular problems such as myocardial infarction or stroke. This medication may cause serious gastrointestinal issues like gastrointestinal bleeding, ulcers, or perforation. Therefore, special care is needed for the elderly or those with a history of gastrointestinal disorders. Patients with peptic ulcers or hypersensitivity to this medication, as well as those with a history of asthma or allergies, should not take this medication. Patients who are pregnant or have severely impaired liver, kidney, or heart function should also avoid this medication. Combining this medication with other non-steroidal anti-inflammatory drugs (NSAIDs), aspirin, diuretics, lithium, methotrexate, anticoagulants, and others may increase the risk of side effects, so it should be avoided or discussed with a doctor. If symptoms such as gastrointestinal bleeding, skin rashes, breathing difficulties, or abnormal liver function occur while taking this medication, it should be stopped immediately, and a doctor should be consulted. Regular blood tests and liver and kidney function tests are required for long-term use, and the medication should be discontinued if any abnormal symptoms occur. Mothers who are breastfeeding should also exercise caution, and it is recommended to stop breastfeeding or discontinuing the medication. Keep this medication out of the reach of children and do not transfer it to another container for safety.

gastrointestinal bleeding, serious cardiovascular thrombotic reactions, myocardial infarction, stroke, bleeding from the stomach or intestines, ulcers, perforation, nausea, vomiting, diarrhea, constipation, abdominal pain, peptic ulcers, shock, rash, itching, anemia, elevated AST, elevated ALT, drowsiness, headache, dizziness, cold sweat, chills, abnormal euphoria, jaundice, fulminant hepatitis, liver necrosis, liver failure, anemia, exfoliative dermatitis, mucous membrane syndrome, toxic epidermal necrolysis, severe bronchospasm

Drug interactions

Do not take this medication with other non-steroidal anti-inflammatory drugs (NSAIDs), ACE inhibitors or angiotensin II receptor antagonists, aspirin, diuretics, lithium, methotrexate, anticoagulants (such as warfarin), cyclosporine and tacrolimus, antiplatelet agents, and selective serotonin reuptake inhibitors (SSRIs), corticosteroids together. Patients taking misoprostol should consult before taking.

This medication should be stored in a sealed container to prevent exposure to air and moisture, ideally at room temperature between 1 to 30 degrees Celsius. Proper storage helps maintain the medication's effectiveness.

Appearance

Blue transparent oval soft capsules containing a translucent yellowish liquid.

Package unit

10 capsules/PTP[*1]